Search research articles
Contact Us
Filters
Showing results (141-150 of 206) with videos related to
Page
of 21
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
January 9, 2007
An evaluation of the variability of tumor-shape definition derived by experienced observers from CT images of supraglottic carcinomas (ACRIN protocol 6658)
Jay S Cooper, Suresh K Mukherji, Alicia Y Toledano, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 19, 2014
Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512)
Andy Trotti, Qiang Zhang, Søren M Bentzen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 4, 2005
A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma
Faye M Johnson, Adam S Garden, J Lynn Palmer, et al.
Bioelectromagnetics
|
July 20, 2016
Biological responses of human solid tumor cells to X-ray irradiation within a 1.5-Tesla magnetic field generated by a magnetic resonance imaging-linear accelerator
Li Wang, Stan Jelle Hoogcarspel, Zhifei Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2011
Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003)
Christine H Chung, James J Dignam, M Elizabeth Hammond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 9, 2014
Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234
Paul M Harari, Jonathan Harris, Merrill S Kies, et al.
The Lancet. Oncology
|
December 20, 2011
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial
Nancy Y Lee, Qiang Zhang, David G Pfister, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 26, 2005
Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes
Smith Apisarnthanarax, Danielle D Elliott, Adel K El-Naggar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 5, 2013
Aortic dose constraints when reirradiating thoracic tumors
Jaden D Evans, Daniel R Gomez, Arya Amini, et al.
American Journal of Clinical Oncology
|
September 1, 2007
Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial
Douglas P Calvin, M E Hammond, Thomas F Pajak, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 206) with videos related to
Sort By:
Page
of 21
International Journal of Radiation Oncology, Biology, Physics
|
January 9, 2007
An evaluation of the variability of tumor-shape definition derived by experienced observers from CT images of supraglottic carcinomas (ACRIN protocol 6658)
Jay S Cooper, Suresh K Mukherji, Alicia Y Toledano, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 19, 2014
Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512)
Andy Trotti, Qiang Zhang, Søren M Bentzen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 4, 2005
A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma
Faye M Johnson, Adam S Garden, J Lynn Palmer, et al.
Bioelectromagnetics
|
July 20, 2016
Biological responses of human solid tumor cells to X-ray irradiation within a 1.5-Tesla magnetic field generated by a magnetic resonance imaging-linear accelerator
Li Wang, Stan Jelle Hoogcarspel, Zhifei Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2011
Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003)
Christine H Chung, James J Dignam, M Elizabeth Hammond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 9, 2014
Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234
Paul M Harari, Jonathan Harris, Merrill S Kies, et al.
The Lancet. Oncology
|
December 20, 2011
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial
Nancy Y Lee, Qiang Zhang, David G Pfister, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 26, 2005
Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes
Smith Apisarnthanarax, Danielle D Elliott, Adel K El-Naggar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 5, 2013
Aortic dose constraints when reirradiating thoracic tumors
Jaden D Evans, Daniel R Gomez, Arya Amini, et al.
American Journal of Clinical Oncology
|
September 1, 2007
Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial
Douglas P Calvin, M E Hammond, Thomas F Pajak, et al.
Page
of 21